 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$26.79 |
$26.84 |
$26.08 |
$26.10 |
622.20K | | 04/19/2024 |
$25.98 |
$26.34 |
$25.91 |
$26.25 |
449.00K | | 04/22/2024 |
$26.19 |
$26.67 |
$25.74 |
$26.10 |
375.20K | | 04/23/2024 |
$26.24 |
$27.09 |
$26.19 |
$26.81 |
497.20K | | 04/24/2024 |
$26.65 |
$26.77 |
$25.78 |
$25.90 |
359.40K |
|
|
| Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and iovera°®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve. | |
|
Pacira BioSciences (PCRX) has the following price history information. Looking back at PCRX historical stock prices for the last five trading days, on April 18, 2024, PCRX opened at $26.79, traded as high as $26.84 and as low as $26.08, and closed at $26.10. Trading volume was a total of 622.20K shares. On April 19, 2024, PCRX opened at $25.98, traded as high as $26.34 and as low as $25.91, and closed at $26.25. Trading volume was a total of 449.00K shares. On April 22, 2024, PCRX opened at $26.19, traded as high as $26.67 and as low as $25.74, and closed at $26.10. Trading volume was a total of 375.20K shares. On April 23, 2024, PCRX opened at $26.24, traded as high as $27.09 and as low as $26.19, and closed at $26.81. Trading volume was a total of 497.20K shares. On April 24, 2024, PCRX opened at $26.65, traded as high as $26.77 and as low as $25.78, and closed at $25.90. Trading volume was a total of 359.40K shares.
PCRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Pacira BioSciences shares, starting with a $10,000 purchase of PCRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/28/2014 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$65.57 |
|
| End price/share: |
$25.90 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-60.50% |
|
| Average Annual Total Return: |
-8.87% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,951.16 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/18/2024 | $26.10 | | 04/19/2024 | $26.25 | | 04/22/2024 | $26.10 | | 04/23/2024 | $26.81 | | 04/24/2024 | $25.90 |
|
|
Free PCRX Email Alerts:
